Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis

Part of paid clinical trials in Mesa, Arizona.

Sponsor
Barnet Dulaney Perkins Eye Centers
Study ID
NCT06953349
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis — PROCEDURE
    The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma

Study Details

Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis

Key Dates

First listed
May 1, 2025
Start date
Mar 31, 2025
Status verified
Mar 2025
Primary completion
Nov 30, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Single Group/Cohort retrospectively utilized
    This will be 300 eyes that have undergone the combination of Phacoemulsification, OMNI Canaloplasty and Hydrus microstent that will successfully lower IOP in ethnically-diverse patients with Open Angle Glaucoma

Primary Outcome Measure

Measured Efficacy of Surgical Process with Phacoemulsification [ Time Frame: 24 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Barnet Dulaney Perkins Eye CenterMesaArizona85206
Derek J Arnson, Master of Education
[email protected]
4804201005
Christine Funke, Medical Doctor
[email protected]
4804201005
Christine Funke, Medical Doctor (PRINCIPAL_INVESTIGATOR)

Find similar trials in Mesa, AZ

Nationwide
Glaucoma trialsOphthalmology trials
By condition
Glaucoma
By specialty
Ophthalmology
By research site
Barnet Dulaney Perkins Eye Center· Mesa, AZ

Related Studies